Last reviewed · How we verify
NCT04940442
Outreach and Choice in Colorectal Cancer Screening
NA trial testing Outreach in Colorectal Cancer Screening in 5,000 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | health services research |
| Enrollment | 5,000 |
| Start date | 1 August 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Outreach
Conditions studied
- Colorectal Cancer Screening — all drugs for Colorectal Cancer Screening →
Sponsor
Stanford University
Who can join
Adults 45 to 75, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this clinical trial will be to compare overall colorectal cancer (CRC) screening participation between an active choice (fecal immunochemical test \[FIT\] or colonoscopy) and a sequential choice (FIT offered first, then colonoscoscopy offered in those still unscreened) arm. Secondarily, we will (1) compare the proportions of FIT vs. colonoscopy per arm, (2) compare active choice vs FIT only in the initial 3 months of the study, (3) characterize changes in physician knowledge and attitudes regarding CRC screening before and after an educational seminar delivered at the launch of the initiative, (4) characterize perceptions regarding the effect of the intervention on clinical practices, and (5) compare detection rates of CRC, adenomas and SSLs per arm, and the operational results of the outreach program across arms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04940442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Outreach
Trials testing the same drug.
- NCT06666192 — The Ohio State University (OSU) SCREEN Community Program · NA · recruiting
- NCT05389397 — De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas · NA · completed
Other recruiting trials for Colorectal Cancer Screening
Currently open trials in the same condition.
- NCT06757192 — CRC Screening in Unscreened Individuals 45-54 · recruiting
- NCT06763432 — Positive Fit to Colonoscopy: Closing the Gap · recruiting
- NCT06821009 — Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening · NA · recruiting
- NCT06666556 — Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, M · Phase 4 · recruiting
- NCT07224750 — A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04940442 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 27 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04940442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing